Affinity Asset Advisors, LLC
- SEC CIK
- 0001773195
- Latest filing
- Aug 13, 2026
KROS holding history
Keros Therapeutics, Inc. in every 13F filed by Affinity Asset Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
KROS overviewAll 13F holders of KROSFull Q2 2026 holdings
- Shares (Q4 2021)
- 0
- Sold out in Q4 2021
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 1
- Since Q3 2021